POSTER SESSION III
Tuesday, March 9, 2004   9:30 AM - 12:00 Noon
Exhibit Hall B and C
GYNECOLOGIC PATHOLOGY
85
Can p53 and c-myc Over-Expression Aid in Predicting Recurrence and Metastasis of Uterine Leiomyosarcomas?
(920)
C Zhang, P Zhang, CJ Sung, MR Quddus, MM Steinhoff, WD Lawrence - Women & Infants Hospital of Rhode Island, Brown Medical School, Providence, RI
86
TSC Proteins, Insulin Signaling Pathway, and Steroid Receptor Co-Factors in Human Uterine Leiomyomata
(909)
JJ Wei, L Chiriboga, M Mizuguchi, H Yee, K Mittal - New York University, New York, NY
87
The Expression of Retinoic Acid Receptor b Is Decreased in Uterine Leiomyomas as Compared to Normal Myometrium
(921)
P Zhang, C Zhang, X Wang, CJ Sung, F Liu, MR Quddus, MM Steinhoff, WD Lawrence - Women & Infants Hospital of Rhode Island, Brown Medical School, Providence, RI
88
Protein Expression Profiling of Physiologic Endometrium Using Cleavable Isotope-Coded Affinity Tag (ICAT)
(814)
TJ Colgan, G Diehl, L DeSouza, MJ Rodrigues, KM Siu - Mount Sinai Hospital, Toronto, ON, Canada; York University, Toronto, ON, Canada
89
Squamous Morules Are Functionally Inert Elements of Premalignant and Malignant Endometrial Neoplasia
(849)
M-C Lin, TA Ince, M Ogden, GL Mutter - Women's and Perinatal Pathology, Brigham and Women's Hospital, Boston, MA; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan
90
The Endometrial Surface Repair-Metaplasia-Neoplasia Continuum: The Significance of the p63 Immunophenotype
(817)
A Cviko, CP Crum - Brigham and Women's Hospital, Boston, MA
91
Evaluation of Endometrial Intraepithelial Neoplasia with Secretory Changes
(833)
TA Ince, M-C Lin, M Ogden, GL Mutter - Women's and Perinatal Pathology, Brigham and Women's Hospital, Boston, MA; Dept. of Pathology, Naitional Taiwan U. Hospital, Taipei, Taiwan
92
Endometrial Glandular Dysplasia-A Newly Identified Non-Cancerous Precursor Lesion Highly Associated with Uterine Papillary Serous Carcinoma
(923)
W Zheng, SX Liang, HH Yu, SK Chambers, PE Schwartz - Yale University School of Medicine, New Haven, CT
93
Expression of E-Cadherin and Beta-Catenin in Endometrioid and Papillary Serous Carcinoma of the Endometrium
(883)
HQ Peng, M Ionescu, R Jeganathan, J Fang, JG Jones - Montefiore Medical Center/AECOM, Bronx, NY
94
eIF-5A Proliferation Is Greater in Serous Endometrial Carcinoma
(828)
DS Heller, BM Cracchiolo, HM Hanauske-Abel, EC Wolff, MH Park, J Coombs - UMDNJ-NJMS, Newark, NJ; NIH, Bethesda, MD
95
Expression of Telomerase Reverse Transcriptase in the Distinction of "Atypical" Tubal Metaplasia of the Endometrium from Uterine Serous Carcinoma
(853)
F Liu, CJ Sung, MR Quddus, C Zhang, MM Steinhoff, WD Lawrence - Women & Infants Hospital, Brown Medical School, Providence, RI
96
Can p53 Protein Reliably Distinguish Serous and Clear Cell Adenocarcinomas from Benign Mimics in Endometrial Samples?
(910)
MM Weir, CM McLachlin - London Health Sciences Centre and the University of Western Ontario, London, ON, Canada
97
Endometrial Polyp Associated with Increased Risk of Cancer Involvement in Postmenopausal Women
(830)
D Hileeto, O Fadare, M Martel, W Zheng - Yale University School of Medicine, New Haven, CT
98
Endometrial Changes in Curettage Prior to the Diagnosis of Atypical Endometrial Hyperplasia and Well Differentiated Endometrioid Carcinoma
(889)
C Rautenberg, P Regitnig, SF Lax - University of Graz, Graz, Austria
99
Clinicopathologic Analysis of 94 Patients with High-Grade Endometrial Carcinomas; A Heterogeneous Group of Aggressive Tumors
(878)
E Oliva, JP Bissonnette, LR Duska, RL Debernardo, Y Sonoda, N Saunders, RA Soslow - Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY
100
Endometrial Adenocarcinoma: A Clinicopathologic Study To Search the Prognostic Significance of VEGF, Topoisomerase IIa, and p21
(919)
EH Zeren, A Uguz, D Gumurdulu, G Seydaoglu, MA Vardar, A Altintas - Çukurova University, Faculty of Medicine, Adana, Turkey
101
Relationships between HER-2/neu Expression and Downstream Regulation of Protein Tyrosine Kinases in Endometrial Carcinoma
(892)
RSJ Ricketts, S Jaffar, R Gupta, CN Otis, PA Krebs - Baystate Medical Center, Western Campus of Tufts University School of Medicine., Springfield, MA
102
Gene Expression Assessed by cDNA Microarray Identifies New Molecular Changes in Endometrioid Endometrial Carcinoma
(874)
G Moreno-Bueno, R Cassia, C Sanchez-Estevez, D Hardisson, M Andujar, A Dopazo, L Lombardia, E Bussaglia, J Prat, X Matias-Guiu, J Palacios - Centro Nacional de Investigaciones Oncologicas, Madrid, Spain; Hospital Universitario La Paz, Madrid, Spain; Hospital Marterno Infantil de Las Palmas, Las Palmas de Gran Canaria, Spain; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Hospital Arnau de Villanova, Lerida, Spain
103
Mucinous Neoplasms Arising in Mature Teratomas: A Clinicopathologic Study of Ovarian and Sacrococcygeal Tumors
(863)
JK McKenney, RA Soslow, TA Longacre - Stanford University, Stanford, CA; Memorial Sloan-Kettering Cancer Center, New York, NY
104
Survivin Expression in Endometrial Carcinoma. A Tissue Microarray Study
(879)
J Pallares, JL Martinez Guitarte, X Dolcet, J Ramos, L Sanchez Verde, J Palacios, J Prat, X Matias-Guiu - Hospital Universitari Arnau de Vilanova, Lleida, Spain; CNIO, Madrid, Spain; Hospital Santa Creu i Sant Pau, Barcelona, Spain
105
Abnormalities in NF-kb Family and Related Proteins in Endometrial Carcinoma. A Tissue Microarray Study
(880)
J Pallares, X Dolcet, JL Martinez Guitarte, P Gallel, L Sanchez Verde, J Palacios, J Prat, X Matias-Guiu - Hospital Universitari Arnau de Vilanova, Lleida, Spain; CNIO, Madrid, Spain; Hospital Santa Creu i Sant Pau, Barcelona, Spain
106
PTEN and p53 Mutations in Endometrial Carcinomas
(902)
K-S Suh, H-S Kim, S-Y Na, J-S Choi, H-T Noh - Chungnam National University School of Medicine, Daejeon, Korea
107
Immunostaining for the Intestinal Transcription Factor CDX2 Can Differentiate Colorectal from Endometrial Adenocarcinoma
(854)
L Liu, M Younes - Baylor College of Medicine and the Methodist Hospital, Houston, TX
108
Small Cell Carcinoma Component in Malignant Mixed Mullerian Tumors of the Uterus
(864)
BK McLaren, M Constantinescu, W Daley, J Albores-Saavedra - Louisiana State University Health Sciences Center, Shreveport, LA; University of Mississippi Medical Center, Jackson, MS
109
EGFR and HER2/neu Overexpression in Endometrial Carcinosarcoma
(856)
CA Livasy, FC Reading, J Sciarrotta, JF Boggess - University of North Carolina, Chapel Hill, NC
110
Lack of Significant c-KIT Expression in Endometrial Carcinosarcoma
(855)
CA Livasy, FC Reading, J Sciarrotta, JF Boggess - University of North Carolina, Chapel Hill, NC